Suitability of reduced dose glucocorticoids therapy regimen for antibody-associated vasculitis patients with TB: a retrospective study-Reference-Cited by-同舟云学术

Suitability of reduced dose glucocorticoids therapy regimen for antibody-associated vasculitis patients with TB: a retrospective study

Published:2024-03-27 Issue:6 Volume:43 Page:1061-1072
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Wen Rui,Xiao Jingni,Ding Ning,Zhong Yong,Yuan Qiong,Li Jiali,Wang Qi,Xie Hebin,Qin Jiao

Funder

Natural Science Foundation of Hunan Province

Health Commission of Hunan Province

Scientific Research Foundation of Education Department of Anhui Province of China

Department of Science and Technology of Hunan Province

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10096-024-04807-w.pdf

Reference35 articles.

1. Liao QQ, Ren YF, Zhu KW et al (2022) Long-term prognostic factors in patients with Antineutrophil cytoplasmic antibody-Associated Vasculitis: a 15-Year Multicenter Retrospective Study[J]. Front Immunol 13:913667

2. Ponte C, Águeda AF, Luqmani RA (2018) Clinical features and structured clinical evaluation of vasculitis[J]. Best Pract Res Clin Rheumatol 32(1):31–51

3. Sherkat R, Mostafavizadeh K, Zeydabadi L et al (2011) Antineutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis[J]. Iran J Immunol 8(1):52–57

4. Satoskar AA, Suleiman S, Ayoub I et al (2017) Staphylococcus infection-Associated GN - Spectrum of IgA Staining and Prevalence of ANCA in a single-center Cohort[J]. Clin J Am Soc Nephrol 12(1):39–49

5. Xun C (2021) Distribution characteristics of ANA and ANCA in patients with Hyperthyroidism[J]. Endocr Metab Immune Disord Drug Targets 21(11):1993–1997